Golnaz Morad
- Cancer Research top 5%
- MicroRNA in disease regulation 4
- Immunology top 5%
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 5
- Oral Surgery top 5%
- Dental Implant Techniques and Outcomes 7
- Urology top 2%
- Periodontal Regeneration and Treatments 8
-
- Extracellular vesicles in disease 10
- Gut microbiota and health 5
- Epigenetics and DNA Methylation 4
-
- Bone Tissue Engineering Materials 4
- Co-authors
- Jennifer A. WargoBeth A. HelminkPadmanee SharmaMarsha A. MosesArash KhojastehCassandra DaisyTae‐Eun ParkChristopher V. Carman
- Cited by
- Cancer ResearchImmunologyOncology
- Journals
- Cancer Research (7 papers)Journal of Craniofacial Surgery (5 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesIranCyprus
In The Last Decade
Golnaz Morad
35 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Cancer Research 491
- Immunology 619
- Oncology 790
- Oral Surgery 180
- Urology 156
Countries citing papers authored by Golnaz Morad
This map shows the geographic impact of Golnaz Morad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Golnaz Morad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Golnaz Morad more than expected).
Fields of papers citing papers by Golnaz Morad
This network shows the impact of papers produced by Golnaz Morad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Golnaz Morad. The network helps show where Golnaz Morad may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Golnaz Morad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2024 | 0 | |
| 4 | Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistancebreakdown → | 2023 | 120 |
| 5 | 2023 | 0 | |
| 6 | 2023 | 0 | |
| 7 | 2021 | 51 | |
| 8 | 2021 | 61 | |
| 9 | Hallmarks of response, resistance, and toxicity to immune checkpoint blockadebreakdown → | 2021 | 1062 |
| 10 | 2020 | 80 | |
| 11 | 2020 | 24 | |
| 12 | 2019 | 1 | |
| 13 | 2014 | 6 | |
| 14 | 2014 | 25 | |
| 15 | 2013 | 1 | |
| 16 | 2013 | 10 | |
| 17 | 2013 | 64 | |
| 18 | 2013 | 17 | |
| 19 | 2013 | 27 | |
| 20 | 2013 | 4 |
About Golnaz Morad
Golnaz Morad is a scholar working on Urology, Oral Surgery, Cancer Research, Orthodontics and Biological Psychiatry, having authored 39 papers that have together received 2.3k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (10 papers), Periodontal Regeneration and Treatments (8 papers), Dental Implant Techniques and Outcomes (7 papers), Gut microbiota and health (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), MicroRNA in disease regulation (4 papers), Bone Tissue Engineering Materials (4 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Cancer Research (491 citations), Immunology (619 citations), Oncology (790 citations), Oral Surgery (180 citations) and Urology (156 citations). Golnaz Morad has collaborated with scholars based in United States, Iran and Cyprus. Frequent co-authors include Jennifer A. Wargo, Beth A. Helmink, Padmanee Sharma, Marsha A. Moses, Arash Khojasteh, Cassandra Daisy, Tae‐Eun Park, Christopher V. Carman, Elliott J. Hagedorn and Leonard I. Zon. Their work appears in journals such as Cancer Research, Journal of Craniofacial Surgery, Journal of Clinical Oncology, The International Journal of Oral & Maxillofacial Implants and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.